Pivotal Study of the Velocity™ pAVF System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.
Also called NCT07153939
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 126 participants
- Sponsor
- Venova Medical
- Registry
-
NCT07153939
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07153939. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pivotal Study of the Velocity™ pAVF System
- Acronym
- VENOS-3
- Condition
- Chronic Kidney Disease
- Condition
- Hemodialysis Access
- Condition
- Arteriovenous Fistula
- Condition
- End Stage Renal Disease (ESRD)
- Intervention (Device)
- Velocity Percutaneous Arteriovenous Fistula
- Lead sponsor
- Venova Medical
Record details
- Record id
cardio:ct-nct07153939- Content hash
37d247931a8e99ee7e22070a218e214937b6ca1613db28c8f2fda189e622d501